Patents
- Transgenic non-human models for lipodystrophy and/or PELDAplication No: EP19382828
- Use of an isolated antigenic peptide derived from protein S100-beta not united to a class II MHC molecule in the prevention, treatment, diagnosis and/or monitoring of Type 1 DiabetesAplication No: ES 2394331 B2
- Use of Atomic Quantum Clusters (AQCs) in the prevention autoimmune diseases.Aplication No: WO2012059571
- Use of Atomic Quantum Clusters (AQCs) in the prevention of cell proliferative disorders, viral infections and autoimmune diseases.Aplication No: EP2457572A1
- Use of Atomic Quantum Clusters (AQCs) in the prevention of viral infections.Aplication No: WO2012059570A1
- Use of derivates of 6-substituted 3-phenylcoumarins and preparation of new derivatesAplication No: WO2010ES70046 20100127
- Use of p53 inhibitors for reducing food intake and lowering body weightAplication No: WO2012ES70111 20120223
- Using RSTN for body weight reductionAplication No: ES20080001306 20080506
- Utilizacion de las yessotoxinas en el tratamiento de procesos alérgicos y asmáticos.Aplication No: P200402943
Pagination
- First page
- Previous page
- 1
- 2
- 3
- 4
- 5
